Mymetics Corp (MYMX)

[Work Harder]

I don't think I have

Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships

Karen M Walker,1 Shinji Okitsu,2,* David W Porter,3,4 Christopher Duncan,3 Mario Amacker,5,† Gerd Pluschke,2 David R Cavanagh,6 Adrian V S Hill,3,4 and Stephen M Todryk1,3

1Department of Applied Sciences, Faculty of Health & Life Sciences, Northumbria University, Newcastle-upon-Tyne, UK
2Swiss Tropical and Public Health Institute, Basel, Switzerland
3Centre for Clinical Vaccinology and Tropical Medicine, Oxford University, Oxford, UK
4The Jenner Institute, Oxford, UK
5Pevion Biotech Ltd., Bern, Switzerland
6Ashworth Laboratories, Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK
Correspondence: S. M. Todryk, Department of Applied Sciences, Faculty of Health & Life Sciences, Northumbria University, Newcastle-upon-Tyne, NE1 8ST, UK., Email: [e-mail], Senior author: Stephen M. Todryk
*Present address: EMD Serono Research and Development Institute Billerica, MA, 01821, USA
†Present address: Mymetics SA 1066, Epalinges, Switzerland

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405325/

hmmm

Acknowledgments
We are grateful to Ed Schwalbe for discussion about the statistics. S. Todryk acknowledges internal funds from Northumbria University. A. Hill is funded by the Wellcome Trust. M. Amacker was previously an employee of Pevion, a company developing vaccines.